FI834529A0 - ANTIKROPPAR MED DUBBEL SPECIFICITET - Google Patents

ANTIKROPPAR MED DUBBEL SPECIFICITET

Info

Publication number
FI834529A0
FI834529A0 FI834529A FI834529A FI834529A0 FI 834529 A0 FI834529 A0 FI 834529A0 FI 834529 A FI834529 A FI 834529A FI 834529 A FI834529 A FI 834529A FI 834529 A0 FI834529 A0 FI 834529A0
Authority
FI
Finland
Prior art keywords
specificitet
antikroppar
dubbel
med
med dubbel
Prior art date
Application number
FI834529A
Other languages
Finnish (fi)
Other versions
FI834529A (en
Inventor
Joanne Martinis
Richard M Bartholomew
Gary S David
Thomas H Adams
James M Frincke
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of FI834529A0 publication Critical patent/FI834529A0/en
Publication of FI834529A publication Critical patent/FI834529A/en
Priority to FI900212A priority Critical patent/FI900212A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1084—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
    • A61K51/109—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin immunoglobulins having two or more different antigen-binding sites or multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI834529A 1982-04-12 1983-12-09 ANTIKROPPAR MED DUBBEL SPECIFICITET. FI834529A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI900212A FI900212A0 (en) 1982-04-12 1990-01-15 POLYDOM SOM PRODUCER MONOCLONAL HYBRIDANTIKROPPAR MED DUBBEL SPECIFITET.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36778482A 1982-04-12 1982-04-12
PCT/US1983/000525 WO1983003679A1 (en) 1982-04-12 1983-04-12 Antibodies having dual specificities, their preparation and uses therefor

Publications (2)

Publication Number Publication Date
FI834529A0 true FI834529A0 (en) 1983-12-09
FI834529A FI834529A (en) 1983-12-09

Family

ID=23448582

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834529A FI834529A (en) 1982-04-12 1983-12-09 ANTIKROPPAR MED DUBBEL SPECIFICITET.

Country Status (11)

Country Link
EP (1) EP0105360A4 (en)
JP (2) JPH0753119B2 (en)
AT (1) AT394577B (en)
AU (1) AU550486B2 (en)
CA (1) CA1213229A (en)
CH (1) CH672796A5 (en)
ES (7) ES8504461A1 (en)
FI (1) FI834529A (en)
GB (4) GB2128631B (en)
IT (1) IT1219778B (en)
WO (1) WO1983003679A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3177776B2 (en) * 1988-09-27 2001-06-18 武田薬品工業株式会社 Hybrid monoclonal antibodies, antibody-producing polydomas and antibody-containing drugs
US5292668A (en) * 1981-12-21 1994-03-08 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
CA1214123A (en) * 1983-01-20 1986-11-18 Masashi Matsui Cell lines for use in the preparation of hybridoma cells
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
EP0467416A1 (en) * 1983-09-01 1992-01-22 Hybritech Incorporated Antibody compositions of therapeutic agents having an extended serum half-life
AU595159B2 (en) * 1984-04-23 1990-03-29 Boston Biomedical Research Institute Incorporated Bispecific antibody determinants
NL8501219A (en) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic IMMUNOLOGICAL COMPLEX, ITS PREPARATION AND APPLICATION.
JP2635343B2 (en) 1986-04-14 1997-07-30 ザ・ジェネラル・ホスピタル・コーポレーション Heterobifunctional antibodies and methods of use
US5453269A (en) * 1986-04-14 1995-09-26 The General Hospital Corporation Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use
FR2604092B1 (en) * 1986-09-19 1990-04-13 Immunotech Sa IMMUNOREACTIVES FOR TARGETING ANIMAL CELLS FOR VISUALIZATION OR DESTRUCTION IN VIVO
GB8626412D0 (en) * 1986-11-05 1986-12-03 Clark M R Antibodies
GB8626413D0 (en) * 1986-11-05 1986-12-03 Gilliland L K Antibodies
US5053226A (en) * 1987-07-15 1991-10-01 Board Of Regents, The University Of Texas System Monoclonal antibodies binding platinum complexes
ES2058199T3 (en) * 1987-09-23 1994-11-01 Bristol Myers Squibb Co ANTIBODY HETEROCONJUGATES FOR THE ELIMINATION OF HIV-INFECTED CELLS.
GB2218100A (en) * 1988-03-02 1989-11-08 Erling Sundrehagen Conjugates for the detection and/or quantification of antigenic substances in body fluids
US4892824A (en) * 1988-03-15 1990-01-09 Synbiotics Corporation Fast track method for producing monoclonal bi-specific immunoglobulins
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
JPH02196799A (en) * 1988-04-08 1990-08-03 Agency Of Ind Science & Technol Complex of anti-human cancer protein
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
IT1235349B (en) * 1988-12-23 1992-06-30 Biodata Spa IMMUNOLOGICAL TEST FOR HOMOGENEOUS DETERMINATIONS
CA2006408A1 (en) * 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
US5217713A (en) * 1988-12-27 1993-06-08 Takeda Chemical Industries, Ltd. Cytotoxic bispecific monoclonal antibody, its production and use
WO1990012109A1 (en) * 1989-03-30 1990-10-18 Board Of Regents, The University Of Texas System Monoclonal antibodies binding platinum complexes
FR2652004B1 (en) * 1989-09-21 1994-10-28 Immunotech Partners NOVEL HYDROPHILIC DERIVATIVES, APPLICATION TO DIAGNOSIS AND THERAPEUTICS, DIAGNOSTIC OR THERAPEUTIC KITS AND IMMUNOLOGICAL REAGENTS.
EP0515571B1 (en) * 1990-02-16 1998-12-02 Boston Biomedical Research Institute Hybrid reagents capable of selectively releasing molecules into cells
TW212184B (en) * 1990-04-02 1993-09-01 Takeda Pharm Industry Co Ltd
DE69214709T2 (en) * 1991-04-26 1997-02-20 Surface Active Ltd New antibodies and methods of using them
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
GB9421468D0 (en) * 1994-10-18 1994-12-07 Surface Active Ltd Biosensor
US6114506A (en) * 1996-09-20 2000-09-05 General Hospital Corporation Composition and method for enhancing fibrinolysis
US20020132274A1 (en) 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
DK1545613T3 (en) 2002-07-31 2011-11-14 Seattle Genetics Inc Auristatin conjugates and their use in the treatment of cancer, an autoimmune disease or an infectious disease
SI2489364T1 (en) 2003-11-06 2015-04-30 Seattle Genetics, Inc. Monomethylvaline compounds conjugated to antibodies
KR101274524B1 (en) 2004-03-16 2013-06-19 온코노바 테라퓨틱스, 인코포레이티드 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
US8288352B2 (en) 2004-11-12 2012-10-16 Seattle Genetics, Inc. Auristatins having an aminobenzoic acid unit at the N terminus
DK1871418T3 (en) 2005-04-19 2014-06-10 Seattle Genetics Inc Humanized anti-CD70 binding agents and uses thereof
ES2908458T3 (en) 2005-07-18 2022-04-29 Seagen Inc Beta-glucuronide drug-linker conjugates
CA2699837C (en) 2006-12-01 2017-06-13 Seattle Genetics, Inc. Variant target binding agents and uses thereof
ATE526017T1 (en) 2007-01-22 2011-10-15 Genentech Inc DEPOSITION OF POLYELECTROLYTES AND PURIFICATION OF ANTIBODIES
CA2723197C (en) 2008-05-02 2017-09-19 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
WO2011133658A1 (en) 2010-04-22 2011-10-27 Boston Medical Center Corporation Compositions and methods for targeting and delivering therapeutics into cells
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
CA2906784C (en) 2013-03-15 2023-02-28 The Centre For Drug Research And Development Cytotoxic and anti-mitotic compounds, and methods of using the same
US10227407B2 (en) 2013-10-10 2019-03-12 Yukinari Kato Anti-podoplanin antibody
AU2014373574B2 (en) 2013-12-27 2020-07-16 Zymeworks Bc Inc. Sulfonamide-containing linkage systems for drug conjugates
RS62860B1 (en) 2014-09-17 2022-02-28 Zymeworks Inc Cytotoxic and anti-mitotic compounds, and methods of using the same
TWI618697B (en) 2015-11-03 2018-03-21 財團法人工業技術研究院 Compounds, linker-drugs and ligand-drug conjugates
CA3017527A1 (en) 2016-03-25 2017-09-28 Seattle Genetics, Inc. Process for the preparation of pegylated drug-linkers and intermediates thereof
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
WO2018175994A1 (en) 2017-03-24 2018-09-27 Seattle Genetics, Inc. Process for the preparation of glucuronide drug-linkers and intermediates thereof
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
CA3110096A1 (en) 2018-08-30 2020-03-05 Innovative Cellular Therapeutics CO., LTD. Chimeric antigen receptor cells for treating solid tumor
EP3965891A1 (en) 2019-05-10 2022-03-16 Takeda Pharmaceutical Company Limited Antibody drug conjugates
TW202138388A (en) 2019-12-30 2021-10-16 美商西根公司 Methods of treating cancer with nonfucosylated anti-cd70 antibodies
US12076343B2 (en) 2020-02-19 2024-09-03 Innovative Cellular Therapeutics Holdings, Ltd. Engineered safety in cell therapy
US12043654B2 (en) 2020-06-02 2024-07-23 Innovative Cellular Therapeutics Holdings, Ltd. Anti-GCC antibody and CAR thereof for treating digestive system cancer
US20220168330A1 (en) 2020-11-09 2022-06-02 Takeda Pharmaceutical Company Limited Antibody drug conjugates
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof
IL309405A (en) 2021-06-29 2024-02-01 Seagen Inc Methods of treating cancer with a combination of a nonfucosylated anti-cd70 antibody and a cd47 antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130634A (en) * 1974-03-15 1978-12-19 University Of Illinois Foundation Method for detecting and quantifying antigens
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies

Also Published As

Publication number Publication date
GB8332646D0 (en) 1984-01-11
GB2169921B (en) 1987-03-04
ES8603080A1 (en) 1985-12-01
GB2167086B (en) 1987-03-04
ES8503441A1 (en) 1985-02-16
ES8604424A1 (en) 1986-02-01
ATA901883A (en) 1991-10-15
GB2128631A (en) 1984-05-02
ES8606655A1 (en) 1986-04-01
AU550486B2 (en) 1986-03-20
AU1555983A (en) 1983-11-04
GB2169921A (en) 1986-07-23
JP2562002B2 (en) 1996-12-11
IT1219778B (en) 1990-05-24
ES527963A0 (en) 1985-02-16
ES533930A0 (en) 1985-12-01
ES538727A0 (en) 1986-02-01
ES521370A0 (en) 1985-04-16
GB2168998A (en) 1986-07-02
JPS6312276A (en) 1988-01-19
GB8530310D0 (en) 1986-01-22
ES8607386A1 (en) 1986-05-16
EP0105360A1 (en) 1984-04-18
ES533931A0 (en) 1985-06-16
ES8506091A1 (en) 1985-06-16
IT8320548A0 (en) 1983-04-12
FI834529A (en) 1983-12-09
EP0105360A4 (en) 1986-07-08
GB2168998B (en) 1987-03-04
ES8504461A1 (en) 1985-04-16
ES545247A0 (en) 1986-05-16
ES537257A0 (en) 1986-04-01
GB2128631B (en) 1987-02-25
WO1983003679A1 (en) 1983-10-27
JPH0753600A (en) 1995-02-28
GB8530309D0 (en) 1986-01-22
JPH0753119B2 (en) 1995-06-07
CA1213229A (en) 1986-10-28
AT394577B (en) 1992-05-11
GB2167086A (en) 1986-05-21
GB8530308D0 (en) 1986-01-22
CH672796A5 (en) 1989-12-29

Similar Documents

Publication Publication Date Title
FI834529A0 (en) ANTIKROPPAR MED DUBBEL SPECIFICITET
FI830212A0 (en) SANITETSBINDA MED FOERBAETTRAD KOMFORT
FI823513A (en) KNIVSLIDA MED EN ENHETLIG BLADSLIPARE
FI830593L (en) TANGENTBORD MED INDENTIFIERINGSORGAN
FI830874L (en) LOCKFOERSETT KAERL MED REGLERBAR OEPPNING
FI830044A0 (en) TILLSLUTNING MED TRANSVERSELLT ROERLIGT MUNSTYCKE
FI830709L (en) KARDANAXEL FOERSEDD MED EN UTRAETNINGSANORDNING
FI830895A0 (en) STJAERNTRIANGELKOPPLARE MED NOLLSPAENNINGSUTLOESNING
FI831214A0 (en) BLYAKKUMULATOR MED EXPANDERFOERRAOD
FI831107A0 (en) MED AEDELMETALL KATALYSERADE REAKTIONER
FI821115L (en) RULLHAOLLARE MED BROMS
FI823309A0 (en) SAONINGSMASKIN MED BETNINGSANORDNING
FI821663A0 (en) ACKUMULATOR MED DUBBEL STROEMKRETS
FI822330A0 (en) BLIXTLAOS MED GJUTNA KRAMPOR
FI821845A (en) STROEMBRYTARE MED KONTAKTSKIVOR
FI822287A0 (en) INLOPPSLAODA FOERSEDD MED TURBULENSGENERATOR FOER PAPPERSMASKIN
FI823393A (en) MED ROTERANDE BORSTVALS FOERSEDD SKRAEPUPPSAMLINGSVAGN
FI823459A0 (en) STROEMNINGSMAETARE MED AXIALTURBIN
FI823245L (en) STEGLOES VAEXEL MED VIDSTRAECKT UTVAEXLINGSOMRAODE
FI822635A0 (en) FOERBRAENNINGSMOTOR MED STYV KOLVSTAONG
FI822545A0 (en) LYFTANORDNINGSSYSTEM FOER HAENGSTAELLNING MED EGET BAERTORN
FI822432A0 (en) MED TREPUNKTSTOEDANDE FOERSEDD LYFTKOEL
FI821384A0 (en) MED HETLUFT VAERMEISOLERAT BOSTADSHUS
FI821892A0 (en) KRAEFTBUR MED FYRA INGAONG
FI830313A0 (en) HOPVIKBAR BAOT MED EN FOER- OCH EN AKTERSEKTION

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HYBRITECH INCORPORATED